Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media
Authors:
Calvén J, Yudina Y, Uller L
In:
PLoS ONE (2013) 8(4): e62718
Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media
Authors:
May RD, Monk PD, Cohen ES, Manuel D, Dempsey F, Davis NH, Dodd AJ, Corkill DJ, Woods J, Joberty-Candotti C, Conroy LA, Koentgen F, Martin EC, Wilson R, Brennan N, Powell J, Anderson IK
In:
Br J Pharmacol (2012) 166(1): 177-93
Categories:
Primary Cells and Media
Authors:
Yamamoto Y, Takase K, Kishino J, Fujita M, Okamura N, Sakaeda T, Fujimoto M, Yagami T
In:
PLoS ONE (2011) 6(3): e17552
Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media
Authors:
Yagami A, Orihara K, Morita H, Futamura K, Hashimoto N, Matsumoto K, Saito H, Matsuda A.
In:
J Immunol (2010) 185(10): 5743-50
Categories:
Primary Cells and Media
Authors:
Kuhn AR, Schlauch K, Lao R, Halayko AJ, Gerthoffer WT, Singer CA
In:
Am J Respir Cell Mol Biol (2010) 42(4): 506-13
Categories:
Primary Cells and Media
Authors:
Erlemann KR, Cossette C, Gravel S, Lesimple A, Lee GJ, Saha G, Rokach J, Powell WS
In:
Free Radic Biol Med (2007) 42(5): 654-64